Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

NCT02846233 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: GLP1 receptor agonist
DRUG: basal insulin
DRUG: SGLT2 inhibitor
DRUG: Metformin

Sponsor

University of California, San Francisco